Closing Date 25/11/2018, 23:55
Division Cancer Therapeutics
Team Clinical Pharmacology & Trials
Vacancy Type Full time
Type of Contract Fixed Term
Length of Contract2 years
Hours per Week 35
Salary Range £30,715 to £39,681
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.
Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.
The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
The Cancer Research UK Cancer Therapeutics Unit, within the Division of Cancer Therapeutics, is a multidisciplinary ‘bench to bedside’ centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. The Cancer Therapeutics Unit’s exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidates to clinical trial. All the scientific disciplines are in place to make this possible.
A Post Doctoral Training Fellow/High Scientific Officer is required by the Drug Metabolism and Pharmacokinetics group in the Division of Cancer Therapeutics to work alongside other members of the team on the pharmacology of new anticancer drugs. The post holder should be able to design, analyse, interpret and report experiments to support the development of novel anticancer agents. Mass spectrometry experience is essential with a desire to develop novel analytical methods to evaluate metabolic and pharmacokinetic properties of novel agents. The ability to model and simulate data is advantageous. The candidate will be an integral part of a multidisciplinary team and will interact closely with chemists, biologists, pharmacologists and computer scientists.
Applicants must have a degree/PhD in Pharmacology, Biology or Analytical Chemistry. An interest in Cancer Biology is desirable.
This is an ideal opportunity for enthusiastic, committed analyst to make an important contribution to improved therapies for cancer patients, while gaining experience and training in drug discovery skills in an institute with a track record of success. Appointment will be to a PDTF or HSO (depending on relevance of skills and experience) with starting salary in the range of £30,715 to £39,681 p.a. inclusive. The post is offered on a fixed term contract of 2 years in the first instance and benefits from a contributory defined benefit pension scheme and generous leave entitlement. To apply please visit the ICR web site ">www.icr.ac.uk.*
We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.